SCHEMBL7454201

SCHEMBL7454201

COc1ccc(C/C=C/c2cccnc2Oc2ccc(F)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
TRPA1 O75762 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
NFE2L2 Q16236 1/20 0.39
PTGER1 P34995 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPBWR1 P48145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7454212 1.00 CYP1A2 (0.46) CYP1A2CYP3A4CYP2D6KDM4EMEN1
SCHEMBL7398206 0.89 KMT2A (0.42) MEN1KMT2ATRPA1NPC1RAB9A
SCHEMBL7398203 0.89 KMT2A (0.42) MEN1KMT2ATRPA1NPC1RAB9A
SCHEMBL7684771 0.75 CHRNB2 (0.44) KMT2A
SCHEMBL7364110 0.73 MEN1 (0.47) CYP1A2CYP3A4CYP2D6KDM4EMEN1
SCHEMBL6142808 0.72 KMT2A (0.46) CYP1A2CYP3A4CYP2D6KDM4EKMT2A
SCHEMBL7400057 0.71 KMT2A (0.49) KMT2ATDP1
SCHEMBL7401972 0.70 CYP1A2 (0.44) CYP1A2CYP3A4CYP2D6KDM4EMEN1
SCHEMBL7374722 0.70 KDM4E (0.44) CYP1A2CYP3A4CYP2D6KDM4EMEN1
SCHEMBL7371446 0.69 LMNA (0.72) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380218-B1 FOR THERAPY OF RESPIRATORY, ALLERGIC, AND INFLAMMATORY DISORDERS COMPRISING ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ACUTE RESPIRATORY DISEASE SYNDROME, PULMONARY HYPERSENSITIVITY, AND ALLERGIC RHINITIS IN A MAMMAL PFIZER INC 2002-04-30 US disclosed
EP-0971894-A1 NICOTINAMIDE DERIVATIVES Pfizer Products Inc. (US) 2000-01-19 EP disclosed
WO-1998045268-A1 NICOTINAMIDE DERIVATIVES PFIZER PRODUCTS INC. (US) 1998-10-15 WO disclosed